
- /
- Supported exchanges
- / US
- / BMKDF.OTCQB
BioMark Diagnostics Inc (BMKDF OTCQB) stock market data APIs
BioMark Diagnostics Inc Financial Data Overview
Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get BioMark Diagnostics Inc data using free add-ons & libraries
Get BioMark Diagnostics Inc Fundamental Data
{
"General": {
"Code": "BMKDF",
"Type": "Common Stock",
"Name": "BioMark Diagnostics Inc",
"Exchange": "OTCQB",
"CurrencyCode": "USD",
"CurrencyName": "US Dollar",
"CurrencySymbol": "$",
"CountryName": "USA",
"CountryISO": "US",
"OpenFigi": "BBG007WX2619",
"ISIN": null,
"CUSIP": null,
"CIK": null,
"EmployerIdNumber": null,
"FiscalYearEnd": "March",
"IPODate": null,
"InternationalDomestic": null,
"Sector": "Healthcare",
"Industry": "Diagnostics & Research",
"HomeCategory": null,
"IsDelisted": false,
"Description": "Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partnership with Rubix LS to develop d..."
}
}
BioMark Diagnostics Inc Fundamental data includes:
- Net Revenue: 155 K
- EBITDA: -1 900 146
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-12-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BioMark Diagnostics Inc News

BioMark Grants Options
Vancouver, British Columbia--(Newsfile Corp. - March 2, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that it has granted 2,100,000 incent...


BioMark Grants Options
Vancouver, British Columbia--(Newsfile Corp. - March 2, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that it has granted 2,100,000 incent...

Macfarlane Group (LON:MACF) Shareholders Have Enjoyed A 41% Share Price Gain
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And while active stock picking involves risks (and requires divers...

Macfarlane Group (LON:MACF) Shareholders Have Enjoyed A 41% Share Price Gain
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And while active stock picking involves risks (and requires divers...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.